Figure 5.

Immune cell phenotype analysis of CD57− NK cells in patients on IMV versus non-IMV. (a) Representative cytometry by time-of-flight (CyTOF) plots showing distribution of CD57− NK cells at baseline in patients requiring IMV compared with non-IMV group. (b) Quantitative analysis of CD57− NK cell frequencies within the CD45+ compartment at baseline. Non-IMV group demonstrated a significantly higher proportion of CD57− NK cells compared with IMV group, suggesting reduced NK cell senescence and preserved proliferative capacity in the non-IMV group. *p < 0.05.